Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN13718455) titled 'Deferred Registration - Quotient Sciences Code: QSC303945' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Phase 1 study in healthy volunteers
Primary Sponsor: Draig Therapeutics Ltd.
Condition:
Healthy volunteers
Other
Intervention:
This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.
Recruitment Status: Not Recruiting
Phase: Phase I
Date of First Enroll...